Zhong Lun advised LaNova Medicines in Completing its CNY 300 Million Series C1 Financing and Entering into Strategic Collaboration with Sino Biopharm. LaNova Medicines Technology (Shanghai)...
LaNova Medicines’ CNY300 Million Series C1 Financing and Strategic Collaboration with Sino Biopharm
SF Diamond v. SF Diamond v. US Synthetic
Steptoe & Johnson LLP secured a significant trial victory for SF Diamond Co., Ltd. and SF Diamond USA, Inc. at the U.S. International Trade Commission (ITC)....